跳至主要内容
临床试验/DRKS00031339
DRKS00031339招募中不适用

on-interventional Study with Ozawade® in patients with obstructive sleep apnea syndrome - Oz-leap

Bioprojet Deutschland GmbH0 个研究点目标入组 1,500 人开始时间: 2023年4月4日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
1,500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • OSA diagnosis according to the International Classification of Sleep Disorders 3rd Edition criteria
  • - Residual excessive daytime sleepiness with ESS >=12
  • despite treatment, or after CPAP treatment attempt (or alternative OSA treatment attempt)
  • - new treatment with Ozawade® (patient is treatment naïve to wake-promoting pharmacotherapy)
  • - Signed informed consent by the patient Exclusion criteri

排除标准

  • Patient is unable to understand the informed consent form.

研究者

相似试验